CE
Celularity Inc.
CELUW · NASDAQ
$0.00 -92.46% (-$0.02)
Market Cap $48.6K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Current Price
$0.0019
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CELUW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.00x
EV/FFO N/A
P/B N/A
Growth
83 /100
Growing Rev. growth 13.88%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 345.44%
Op. margin 230.92%
FCF margin 49.92%
Quality
4 /100
Poor ROA 85.45%
Asset turnover 0.25x
ROIC 151.11%
Debt
0 /100
High Int. coverage -12.58x
Current ratio 0.15x
Net debt/EBITDA N/A
Stability
22 /100
Unstable Rev. volatility 95.07%
EPS volatility 743.15%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CELUW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert Joseph Hariri
Employees
115
Headquarters
Florham Park